1 "Paraganglioma" clinical study found.

• DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

  This clinical trial studies nivolumab and ipilimumab in treating patients with rare tumors.

  Kathy Miller, Md